Starzl T E, Klintmalm G B, Iwatsuki S, Weil R
Surg Gynecol Obstet. 1981 Sep;153(3):377-82.
Thoracic duct drainage was added to conventional immunosuppression with azathioprine, prednisone and, sometimes, antilymphocyte globulin in 83 patients given cadaveric kidneys, including 65 primary graft recipients. The most effective use of thoracic duct drainage was for pretreatment. Optimal conditioning was at least four weeks duration, and when lymph drainage was this long, the incidence of rejection during the first three postoperative months was reduced to 4.5 per cent. Shorter pretreatment or institution of thoracic duct drainage contemporaneous with transplantation were less effective, but the one year results were still better than those with conventional immunosuppression alone. However, the advantage gained with thoracic duct drainage during the first year was diminished in all the treatment groups by graft losses in the second postoperative year. It was concluded that, without better maintenance therapy, the full value of temporary early lymphoid depletion procedures cannot be fully exploited.
在83例接受尸体肾移植的患者中,除了使用硫唑嘌呤、泼尼松,有时还使用抗淋巴细胞球蛋白进行常规免疫抑制治疗外,还增加了胸导管引流术,其中包括65例初次接受移植的患者。胸导管引流术最有效的应用是在预处理阶段。最佳的预处理持续时间至少为四周,当淋巴引流持续这么长时间时,术后前三个月的排斥反应发生率降至4.5%。较短时间的预处理或与移植同时进行胸导管引流术效果较差,但一年的结果仍优于单纯常规免疫抑制治疗。然而,在术后第二年,由于移植肾丢失,所有治疗组在第一年通过胸导管引流术获得的优势都有所减弱。得出的结论是,如果没有更好的维持治疗,早期临时淋巴细胞清除程序的全部价值就无法得到充分发挥。